Health
-
Hospitals Scramble as Antibody Treatments Fail Against Omicron
Hospitals, drug companies and Biden administration officials are racing to address one of the Omicron variant’s biggest threats: Two of…
-
They Lost Three Daughters to Sickle Cell. Can They Save a Fourth?
KANO, Nigeria — The hip pain from sickle cell disease was so intense that Sadiya Haruna, age 9, could not…
-
Biogen Slashes Price of Alzheimer’s Drug Aduhelm, as It Faces Obstacles
Biogen slashed the price of its controversial new Alzheimer’s drug Aduhelm on Monday as the drug faces weak sales and…
-
Novavax’s Covid Vaccine Is Authorized in Europe
The European Commission on Monday authorized a Covid-19 vaccine made by Novavax, making it the fifth vaccine available in the…
-
C.D.C. Says Unvaccinated Students Exposed to Virus Can ‘Test and Stay’
WASHINGTON — The Centers for Disease Control and Prevention said on Friday that unvaccinated students exposed to the coronavirus can…
-
“Schizophrenia” Still Carries a Stigma. Will Changing the Name Help?
For decades, Linda Larson has been trying to distance herself from the diagnosis she was given as a teenager: schizophrenia.…
-
Most of the World’s Vaccines Likely Won’t Prevent Infection From Omicron
A growing body of preliminary research suggests the Covid vaccines used in most of the world offer almost no defense…
-
C.D.C. Says Unvaccinated Students Exposed to Virus Can ‘Test and Stay’
WASHINGTON — The Centers for Disease Control and Prevention said on Friday that unvaccinated students exposed to the coronavirus can…
-
A Popular Test Claims to Boost I.V.F. Success. The Science Is Unclear.
For patients undergoing in vitro fertilization, there is a common test to help determine the best time to transfer the…
-
Judge Overturns Purdue Pharma’s Opioid Settlement
A federal judge on Thursday evening unraveled a painstakingly negotiated settlement between Purdue Pharma and thousands of state, local and…